The National Health Surveillance Agency (ANVISA in Portuguese) has taken an additional step in reviewing the classification process for border products. The call for proposals 9/2025, dated August 8, was published this Monday (August 11), inviting contributions to the Preliminary Report on Regulatory Impact Analysis (AIR in Portuguese) regarding this matter.

Border products are those that raise questions about their classification—whether they are medications, cosmetics, food, or medical devices—due to their characteristics, such as composition, usage, appearance, and mode of action. They are referred to as “border products” until ANVISA determines the correct category and the regulations that must be followed.